EAN News

EANpages is the electronic news tool of EAN reporting on what happens in the neurological and allied-disciplines field, in the EAN community, and providing informed opinions on different scientific and healthcare related topics in neurology. The EANpages Editor-in-Chief is expected… Continue Reading

8th Winter Course on Movement Disorders 54th Turkish National Neurology Congress

In Europe, there are approximately 740 million people, most of whom experience an episode of severe pain at some point in their life. For approximately 20 percent, that pain is chronic – episodic, persistent, or variable. In other words, today… Continue Reading

The Sixty-eight session of the World Health Organisation Regional Committee for Europe took place in Rome, Italy (16 – 20 September, 2018).                   Health ministers and high-level representatives of the 53 Member States… Continue Reading

he Congress will begin each morning and afternoon with Plenary Sessions providing overviews of the phenomenology, pathophysiology, and current diagnostic and therapeutic strategies of various movement disorders. These sessions will be followed by Parallel Tracks, permitting participants to select specific diagnostic or therapeutic areas for more concentrated study.

Despite its large use, recommendations for the use of brain F-18 FDG-PET in clinical practice were still lacking. The European Academy of Neurology (EAN) and the European Association of Nuclear Medicine (EANM) promoted a concerted action with 7 specialists from the two Societies and a group of facilitators in order to make the point on this issue. Extensive literature review and analysis of available data led, together with expert opinion (Delphi consensus), to deliver these recommendations that cover practically all the main brain neurodegenerative conditions causing cognitive impairment.

The Guideline will address important areas of dementia management where the medical doctor plays a pivotal role, which includes treatment of epilepsy in dementia, pain in dementia, treatment with antipsychotics in dementia, vascular risk factors in dementia and systematic medical follow-up in dementia.

Prof. G. Deuschl, President of the EAN and Prof. W. Wick President of EANO are pleased to announce that: EAN has joined with EANO to promote optimal management of neuro-oncological care in neurology in Europe.

Scientific plagiarism is defined as using or closely imitating scientific content from an original author without clear reference and/or authorization. Plagiarism can be complete or partial, in the original or translated version or limited to paraphrases of the original text. A textual repetition of one’s own work in subsequent submissions is considered self-plagiarism and should be avoided or at least accompanied by proper referencing to one’s prior work.

Sub-committee and working group chairs
Members of committees Are you eager to shape the future of Neurology in Europe in parallel to developing your professional standing and leadership skills? Following the formation of a new Executive Board of the EAN… Continue Reading

Dear members of the EAN, following the election of 5 members of the EAN Executive Board in Lisbon this new Board will appoint the chair of the education committee and the chair of the program committee. We therefore solicit the… Continue Reading